Retraction Watch

Yes, we are seeing more attacks on academic freedom: guest post by historian of science and medicine

We’re pleased to introduce readers to Alice Dreger, a historian of science and medicine at the Medical Humanities and Bioethics Program in Northwestern University’s Feinberg School of Medicine. Her new book is “Galileo’s Middle Finger: Heretics, Activists, and the Search for Justice in Science,” out this week from Penguin Press. Read to the end for a chance to win a free copy.

The good news: Policy makers and the public seem to be increasingly taking scientific research seriously. The bad news? People who don’t like researchers’ findings seem to be increasingly coming after researchers and their universities. And some of those people are powerful.

Technically, your university is supposed to protect your academic freedom. In my own university’s faculty handbook, academic freedom is the first topic discussed. But as I’ve learned from my own personal experiences, as well as from eight years studying the experiences of other researchers who have gotten into political hot water, your administration may not always have your back. Continue reading Yes, we are seeing more attacks on academic freedom: guest post by historian of science and medicine

Bielawski and Wiggins up retraction count to five with three in JACS

The Journal of the American Chemical Society (JACS) has retracted three articles that had earned expressions of concern by chemistry researchers who were under investigation at the University of Texas, Austin.

Kelly Wiggins and Christopher Bielawski have already received two other retractions and several EoCs.

The newly retracted articles have each been cited more than 50 times, according to Thomson Scientific’s Web of Knowledge.

The three papers are: Continue reading Bielawski and Wiggins up retraction count to five with three in JACS

Opaque retraction notice for imaging paper

Sometimes we run across retraction notices that are vague, and others that are contorted, but we’ve just found one that gets highest marks for being completely inscrutable.

The article, “Bayes Clustering and Structural Support Vector Machines for Segmentation of Carotid Artery Plaques in Multicontrast MRI,” was written by a group from China and Cambridge University in England — so, we’re thinking language ought not to have been much of a barrier to clear English. It appeared in November 2012 in Computational and Mathematical Methods in Medicine, and describes a way to analyze carotid artery plaque levels in MRI images.

But according to the notice, the technique did not work as planned (or so we think):

Continue reading Opaque retraction notice for imaging paper

PubPeer Selections: Feedback within a day; “worst examples of data;” endocrinology papers questioned

PubPeer won a near-complete victory in a court case last week. Here’s another installment of PubPeer Selections: Continue reading PubPeer Selections: Feedback within a day; “worst examples of data;” endocrinology papers questioned

Biofuels paper burned by “improper citation methods” – ie, plagiarism

Critical Reviews in Environmental Science and Technology (CREST) has retracted a paper on biofuels for “improper citation methods.”

Given the journal’s track record, we’re guessing this is just another euphemism for plagiarism. (Also because the retraction notice flags a “breach of warranties made by the authors with respect to originality.”) In 2013, CREST retracted two papers for failing to use “proper citation,” which earned it top billing in our Lab Times column about publishers’ seemingly allergic reactions to the P-word.

Here’s some of the notice for “Promising Unconventional Pretreatments for Lignocellulosic Biomass”, which described new ways to process plant biomaterials into fuel: Continue reading Biofuels paper burned by “improper citation methods” – ie, plagiarism

Misconduct dissolves paper on possible clot-busters

Drug researchers in India have lost their 2013 paper in ACS Medicinal Chemistry Letters because the first author fabricated findings.

The article, by a group from the Maharaja Sayajirao University of Baroda, Vadodara, in Gujarat, was attempting to synthesize and screen novel clot-busting drugs; one compound exhibited the same activity as aspirin or warfarin, but without increasing bleeding time.

Sadly, it appears as if this potential medical advance was not to be. Here’s the retraction notice for “Novel 2-Aminobenzamides as Potential Orally Active Antithrombotic Agents”: Continue reading Misconduct dissolves paper on possible clot-busters

Do fraudsters deserve a second chance?

In January, we were accused of bullying.

We were writing about a researcher who had 16 papers retracted for fake peer reviews; when we found out he was trying to find a new job in academia, we posted a follow-up that linked to his CV. Some commenters called the post “bullying,” “unethical,” and “over the line.” Not everyone agreed, but the back-and-forth prompted us to think about when such follow-ups were appropriate, and whether scientists who’ve committed fraud deserve a second chance. Continue reading Do fraudsters deserve a second chance?

Chinese heavy metal contamination paper purged for data theft

An environmental journal has retracted a paper about pollution in China after it discovered the authors lifted the dataset from another group.

The authors of the study — which chronicled the degree of heavy metal pollution on the banks of the Pearl River Delta — didn’t have permission to use the data. Environmental Monitoring and Assessment‘s notice doesn’t suggest the data are inaccurate.

The heavy metals in the soil come from the many manufacturing plants in the area, including those that provide the West with blue jeans, phones, and other electronics. The pollutants’ effects are wide-reaching: According to the South China Morning Post, industrial outfits discharge huge volumes of toxic chemicals into the Pearl River, including arsenic, copper, cadmium, and mercury.

Continue reading Chinese heavy metal contamination paper purged for data theft